Can axillary radiotherapy replace axillary dissection for early-stage breast cancer?
Farin F Amersi and Armando E Giuliano*
Correspondence *Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
Email giulianoa@jwci.org
This article has no abstract so we have provided the first paragraph of the full text.
ALND has been practiced routinely for breast cancer to achieve staging, provide regional control and improve survival. Over the past decade, sentinel lymph-node (SLN) biopsy has replaced routine ALND for node-negative patients.1, 2, 3 The reduction in surgery and increasing use of chemotherapy and radiation has resulted in the role of ALND being questioned, even for node-positive patients.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.